AtriCure (ATRC) Cash & Equivalents (2016 - 2025)
Historic Cash & Equivalents for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $147.9 million.
- AtriCure's Cash & Equivalents rose 1345.0% to $147.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.9 million, marking a year-over-year increase of 1345.0%. This contributed to the annual value of $122.7 million for FY2024, which is 4555.92% up from last year.
- AtriCure's Cash & Equivalents amounted to $147.9 million in Q3 2025, which was up 1345.0% from $117.8 million recorded in Q2 2025.
- In the past 5 years, AtriCure's Cash & Equivalents ranged from a high of $147.9 million in Q3 2025 and a low of $28.1 million during Q1 2022
- Moreover, its 5-year median value for Cash & Equivalents was $77.3 million (2023), whereas its average is $80.3 million.
- As far as peak fluctuations go, AtriCure's Cash & Equivalents surged by 29226.32% in 2021, and later tumbled by 6704.03% in 2022.
- Quarter analysis of 5 years shows AtriCure's Cash & Equivalents stood at $43.7 million in 2021, then skyrocketed by 33.09% to $58.1 million in 2022, then surged by 45.11% to $84.3 million in 2023, then skyrocketed by 45.56% to $122.7 million in 2024, then rose by 20.49% to $147.9 million in 2025.
- Its Cash & Equivalents was $147.9 million in Q3 2025, compared to $117.8 million in Q2 2025 and $99.9 million in Q1 2025.